Comparison of antiangina therapies in patients with coronary heart disease in China: study protocol for a multicentre, retrospective, hospital system-based study
Cited by 4
Related Papers
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176
Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy
|Biomaterials|2022|166
Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
|Science China Life Sciences|2020|159
Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance
|Cardiovascular Diabetology|2023|113